Karah Herdman Parschauer
General Counsel at Ultragenyx Pharmaceutical Inc. (RARE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $488K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 4SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 1,90092,562 held (−2%) | $24.92 | $47K | -37.9% |
| Jun 15SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 1,89994,462 held (−2%) | $24.62 | $47K | -37.1% |
| Mar 10SEC | RAREUltragenyx Pharmaceutical Inc. | Sell | 6,01870,328 held (−8%) | $21.40 | $129K | -27.7% |
| Mar 10SEC | RAREUltragenyx Pharmaceutical Inc. | Sell | 3,50866,820 held (−5%) | $22.67 | $80K | -31.7% |
| Mar 3SEC | RAREUltragenyx Pharmaceutical Inc. | Sell | 8,13576,346 held (−10%) | $22.80 | $185K | -32.1% |
- Sell
General Counsel Karah Herdman Parschauer sold $47K of RARE at $24.92 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Karah Herdman Parschauer sold $47K of RARE at $24.62 — pre-scheduled 10b5-1 plan sale.